These Cholesterol-Reducers May Save Lives. So Why Aren’t Heart Patients Getting Them?

Tuesday, October 2, 2018 - 02:00 in Health & Medicine

Powerful PCSK9 inhibitors were supposed to revolutionize care for cardiac patients. But insurers and other payers balked at sky-high prices.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net